×
Teligent Operating Income 2010-2021 | TLGT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Teligent operating income from 2010 to 2021. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Historical Chart (TTM)
Quarterly
Quarterly - YOY Change
Annual
Annual % Change
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19.4B
Dr Reddy's Laboratories (RDY)
$11.2B
BridgeBio Pharma (BBIO)
$6.9B
Bausch Health Cos (BHC)
$2.4B
Supernus Pharmaceuticals (SUPN)
$1.9B
Amphastar Pharmaceuticals (AMPH)
$1.5B
Personalis (PSNL)
$412M
Taysha Gene Therapies (TSHA)
$336M
Assembly Biosciences (ASMB)
$81M
Sol-Gel Technologies (SLGL)
$16M
Evoke Pharma (EVOK)
$8M